You can adjust all of your cookie settings using the tabs to the left.
I need rapid, actionable genomic testing without the data analysis bottlenecks.
Fabric Genomics’ AI-driven software platform enables clinical labs to uncover critical and timely genomic insights that reduce costs and save lives
Speeding up diagnostics across key clinical applications
Combine genotype and phenotype data to identify and prioritize rare disease-causing variants using machine learning
NICU / PICU
Accelerate analysis to deliver timely, critical diagnoses for acutely ill infants
Leverage AI and a proprietary variant database to generate customized hereditary reports
Match cancer variants with treatments and clinical trials for physician-ready oncology reports
You're in good company
What our customers say about us
Fabric Genomics’ technology and expertise help us to achieve our mission of interpreting genomic data on an industrial scale. We are very grateful for the team’s fast turnaround times and support, which means that NHS clinicians and patients in the 100,000 Genomes Project can be provided with meaningful clinical information.
Dr. Damian Smedley, Director of Genomic Interpretation at Genomics England
Accuracy, usability and speed are critical in the application of genetic interpretation, which is why we chose to work with [Fabric Genomics] as a key partner in the process.
Dr. Stephen Kingsmore, President and CEO, Rady Children’s Institute for Genomic Medicine
Hospitals need to diagnose life-threatening genetic illnesses quickly and efficient. NGS data interpretation is a critical bottleneck.
Every minute counts
In genomic testing applications, such as pediatrics, rare disease diagnosis, and oncology, time is of the essence. The sooner you can detect a problem, the more likely you’ll be able to stop it before it’s too late.
The cost of delayed detection
Slow turnaround times and diagnostic yields can have grave consequences. Undetected genetic illnesses lead to poor outcomes for your patients and substantial healthcare costs.
Powered by AI, Fabric Enterprise enables clinical genomic testing at scale for faster diagnosis and treatment
One platform. Any test.
Leverage a single comprehensive platform to analyze any NGS test — genomes, exomes, and panels.
Reduce turn-around time and labor costs with streamlined workflows for annotating, interpreting, reporting generation, and sign-off
Higher diagnostic yields.
Identify the causative variant quickly and accurately with diagnostic yields of up to 50%, versus industry average of 25-30%
Sequence to physician-ready reports.
Deliver customizable clinical reports ready to sign out in less than 2hrs for whole genome tests.
Ready to get started?
Watch Now: Applying Artificial Intelligence to Accelerate Variant Classification and Clinical Reporting of NGS Gene Panels
Watch the talk by Francisco De La Vega to see how panel testing with Fabric ACE enables clinical labs to perform rapid genomic interpretation to uncover critical insights that reduce costs and save lives.
Labs from every sector- private, reference, hospital, and academic- may be considering expansion of their test offering to include next generation sequencing (NGS). However, before implementing NGS, there are a number of factors that lab leaders must carefully consider to ensure that successful implementation and sustainability of their NGS program. Join XIFIN and Fabric Genomics …
Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a distribution agreement with XIFIN, a …
Join Martin Reese at the Round Table Discussion at Keystone Symposia 2020- Beyond a Million Genomes: From Discovery to Precision Health
Academia – Industry Collaboration to Enable Genomic Discovery and Implementation of Precision Medicine, Friday, January 24th.
“Benchmarking an artificial intelligence method for fast diagnosis of rare genetic disease.” Monday, February 24, 7:30-7:50 pm
Visit us at booth 831
Visit us at booth 662